| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 8.80e-05 | 599 | 76 | 10 | GO:0050839 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 3.95e-07 | 187 | 75 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | central nervous system development | KRAS PLXNA3 FLNA DLG5 ABR CELSR2 DSCAM PLXNA4 KDM2B LRP5 DAAM2 ZNF76 TAF1 ATXN1L DSCAML1 NDUFS3 | 4.97e-06 | 1197 | 75 | 16 | GO:0007417 |
| GeneOntologyBiologicalProcess | axon guidance | 9.12e-06 | 285 | 75 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 9.35e-06 | 286 | 75 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | KRAS FLNA IFT140 DLG5 ABR DSCAM PTPRM HRAS PDX1 KDM2B LRP5 TNNI1 DSCAML1 WNK4 BSX DNAH11 | 1.04e-05 | 1269 | 75 | 16 | GO:0009887 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.80e-05 | 313 | 75 | 8 | GO:0098742 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FLNA DLG5 CELSR3 CELSR2 DSCAM PTPRM PECAM1 SHB LRP5 TLN2 CDH4 TNXB DSCAML1 CDH18 | 2.91e-05 | 1077 | 75 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | KRAS ARR3 NRAS CELSR3 DSCAM PECAM1 SHB CD109 HRAS LRP5 PLEC TNXB GFRA1 WNK4 XRCC6 | 2.93e-05 | 1226 | 75 | 15 | GO:0042325 |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in axon guidance | 3.03e-05 | 17 | 75 | 3 | GO:0048841 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 3.14e-05 | 246 | 75 | 7 | GO:0045216 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | KRAS ARR3 NRAS CELSR3 PECAM1 SHB CD109 HRAS LRP5 PLEC TNXB GFRA1 WNK4 XRCC6 | 5.07e-05 | 1133 | 75 | 14 | GO:0001932 |
| GeneOntologyBiologicalProcess | brain development | KRAS PLXNA3 FLNA DLG5 ABR CELSR2 PLXNA4 KDM2B TAF1 ATXN1L DSCAML1 NDUFS3 | 5.88e-05 | 859 | 75 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 6.77e-05 | 22 | 75 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 6.77e-05 | 22 | 75 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | adherens junction organization | 7.19e-05 | 61 | 75 | 4 | GO:0034332 | |
| GeneOntologyBiologicalProcess | cytokine precursor processing | 7.79e-05 | 4 | 75 | 2 | GO:0140447 | |
| GeneOntologyBiologicalProcess | protein localization to cell-cell junction | 8.85e-05 | 24 | 75 | 3 | GO:0150105 | |
| GeneOntologyBiologicalProcess | head development | KRAS PLXNA3 FLNA DLG5 ABR CELSR2 PLXNA4 KDM2B TAF1 ATXN1L DSCAML1 NDUFS3 | 1.12e-04 | 919 | 75 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | tube development | KRAS PCSK5 FLNA IFT140 DLG5 NRAS PTPRM PECAM1 SHB PLXNA4 PDX1 KDM2B LRP5 ATXN1L WNK4 | 1.34e-04 | 1402 | 75 | 15 | GO:0035295 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 1.46e-04 | 803 | 75 | 11 | GO:0030036 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | KRAS ARR3 NRAS CELSR3 DSCAM PECAM1 SHB CD109 HRAS LRP5 PLEC TNXB GFRA1 WNK4 XRCC6 | 1.56e-04 | 1421 | 75 | 15 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | KRAS ARR3 NRAS CELSR3 DSCAM PECAM1 SHB CD109 HRAS LRP5 PLEC TNXB GFRA1 WNK4 XRCC6 | 1.58e-04 | 1423 | 75 | 15 | GO:0051174 |
| GeneOntologyBiologicalProcess | trigeminal nerve morphogenesis | 1.94e-04 | 6 | 75 | 2 | GO:0021636 | |
| GeneOntologyBiologicalProcess | trigeminal nerve structural organization | 1.94e-04 | 6 | 75 | 2 | GO:0021637 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 2.05e-04 | 148 | 75 | 5 | GO:1902414 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | KRAS ARR3 NRAS CELSR3 PECAM1 SHB CD109 HRAS LRP5 TAF1 PLEC TNXB GFRA1 WNK4 XRCC6 | 2.58e-04 | 1488 | 75 | 15 | GO:0031399 |
| GeneOntologyBiologicalProcess | regulation of locomotion | PCSK5 PLXNA3 FLNA DLG5 EPPK1 ABR DSCAM PTPRM FURIN PECAM1 HRAS PLXNA4 DAAM2 TNXB | 2.69e-04 | 1327 | 75 | 14 | GO:0040012 |
| GeneOntologyBiologicalProcess | branchiomotor neuron axon guidance | 2.71e-04 | 7 | 75 | 2 | GO:0021785 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | PLXNA3 FLNA CELSR3 CELSR2 DSCAM PTPRM PECAM1 PLXNA4 KIF5A PLEC CDH4 DSCAML1 CDH18 | 3.39e-04 | 1194 | 75 | 13 | GO:0000902 |
| GeneOntologyBiologicalProcess | regionalization | 3.40e-04 | 478 | 75 | 8 | GO:0003002 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 3.58e-04 | 167 | 75 | 5 | GO:0007043 | |
| GeneOntologyBiologicalProcess | protein-containing complex remodeling | 3.84e-04 | 39 | 75 | 3 | GO:0034367 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | PCSK5 PLXNA3 FLNA DLG5 EPPK1 ABR PTPRM FURIN PECAM1 HRAS PLXNA4 DAAM2 TNXB | 3.88e-04 | 1211 | 75 | 13 | GO:0030334 |
| GeneOntologyBiologicalProcess | midbrain development | 4.33e-04 | 97 | 75 | 4 | GO:0030901 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 4.37e-04 | 912 | 75 | 11 | GO:0030029 | |
| GeneOntologyBiologicalProcess | axon development | 5.22e-04 | 642 | 75 | 9 | GO:0061564 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 5.63e-04 | 104 | 75 | 4 | GO:0030516 | |
| GeneOntologyBiologicalProcess | facial nerve structural organization | 5.76e-04 | 10 | 75 | 2 | GO:0021612 | |
| GeneOntologyBiologicalProcess | pattern specification process | 6.39e-04 | 526 | 75 | 8 | GO:0007389 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | PCSK5 PLXNA3 FLNA DLG5 EPPK1 ABR PTPRM FURIN PECAM1 HRAS PLXNA4 DAAM2 TNXB | 6.56e-04 | 1280 | 75 | 13 | GO:2000145 |
| GeneOntologyBiologicalProcess | neuron projection development | PLXNA3 FLNA DLG5 CELSR3 CELSR2 DSCAM PTPRM PLXNA4 KIF5A CDH4 TNXB DSCAML1 GFRA1 | 6.81e-04 | 1285 | 75 | 13 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | PLXNA3 FLNA IFT140 DLG5 CELSR3 CELSR2 DSCAM PTPRM PLXNA4 KIF5A CDH4 TNXB DSCAML1 GFRA1 | 7.17e-04 | 1463 | 75 | 14 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 7.95e-04 | 114 | 75 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 8.10e-04 | 418 | 75 | 7 | GO:0051962 | |
| GeneOntologyBiologicalProcess | facial nerve morphogenesis | 8.41e-04 | 12 | 75 | 2 | GO:0021610 | |
| GeneOntologyBiologicalProcess | facial nerve development | 8.41e-04 | 12 | 75 | 2 | GO:0021561 | |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 8.98e-04 | 52 | 75 | 3 | GO:0042789 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 8.98e-04 | 52 | 75 | 3 | GO:0071526 | |
| GeneOntologyBiologicalProcess | cranial nerve structural organization | 9.92e-04 | 13 | 75 | 2 | GO:0021604 | |
| GeneOntologyBiologicalProcess | trigeminal nerve development | 9.92e-04 | 13 | 75 | 2 | GO:0021559 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 1.02e-03 | 122 | 75 | 4 | GO:0061387 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.03e-03 | 566 | 75 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.15e-03 | 14 | 75 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | signal peptide processing | 1.15e-03 | 14 | 75 | 2 | GO:0006465 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 1.17e-03 | 57 | 75 | 3 | GO:0009299 | |
| GeneOntologyBiologicalProcess | neuron recognition | 1.30e-03 | 59 | 75 | 3 | GO:0008038 | |
| GeneOntologyBiologicalProcess | motor neuron migration | 1.33e-03 | 15 | 75 | 2 | GO:0097475 | |
| GeneOntologyCellularComponent | anchoring junction | KRAS FLNA DLG5 EPPK1 PTPRM PECAM1 ANO7 TLN2 PLEC CDH4 WNK4 CDH18 | 1.52e-04 | 976 | 74 | 12 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | 2.34e-04 | 591 | 74 | 9 | GO:0005911 | |
| HumanPheno | Linear nevus sebaceous | 6.99e-08 | 3 | 22 | 3 | HP:0010817 | |
| HumanPheno | Nevus sebaceous | 6.96e-07 | 5 | 22 | 3 | HP:0010815 | |
| HumanPheno | Epidermal nevus | 1.50e-05 | 12 | 22 | 3 | HP:0010816 | |
| HumanPheno | Abnormal metatarsal ossification | 1.78e-05 | 2 | 22 | 2 | HP:0008371 | |
| HumanPheno | Hemimegalencephaly | 2.47e-05 | 14 | 22 | 3 | HP:0007206 | |
| HumanPheno | Cranial asymmetry | 4.57e-05 | 17 | 22 | 3 | HP:0000267 | |
| HumanPheno | Vertebral segmentation defect | 4.61e-05 | 162 | 22 | 6 | HP:0003422 | |
| HumanPheno | Nevus spilus | 5.33e-05 | 3 | 22 | 2 | HP:0025510 | |
| HumanPheno | Subcutaneous hemorrhage | 6.98e-05 | 258 | 22 | 7 | HP:0001933 | |
| HumanPheno | Deviation of the 2nd finger | 7.60e-05 | 20 | 22 | 3 | HP:0009468 | |
| HumanPheno | Arachnoid cyst | 9.50e-05 | 58 | 22 | 4 | HP:0100702 | |
| HumanPheno | Abnormal arachnoid mater morphology | 1.02e-04 | 59 | 22 | 4 | HP:0100700 | |
| HumanPheno | Renal cortical hyperechogenicity | 1.06e-04 | 4 | 22 | 2 | HP:0033132 | |
| HumanPheno | Abnormality of blood circulation | 1.18e-04 | 498 | 22 | 9 | HP:0011028 | |
| HumanPheno | Abnormal shape of the occiput | 1.23e-04 | 119 | 22 | 5 | HP:0011217 | |
| HumanPheno | Prominent occiput | 1.24e-04 | 62 | 22 | 4 | HP:0000269 | |
| HumanPheno | Abnormal occipital bone morphology | 1.33e-04 | 121 | 22 | 5 | HP:0012294 | |
| HumanPheno | Kyphoscoliosis | 1.34e-04 | 196 | 22 | 6 | HP:0002751 | |
| HumanPheno | Mitral valve prolapse | 1.43e-04 | 123 | 22 | 5 | HP:0001634 | |
| HumanPheno | Hemihypertrophy | 1.51e-04 | 25 | 22 | 3 | HP:0001528 | |
| HumanPheno | Adenoma sebaceum | 1.51e-04 | 25 | 22 | 3 | HP:0009720 | |
| HumanPheno | Hypophosphatemic rickets | 1.51e-04 | 25 | 22 | 3 | HP:0004912 | |
| HumanPheno | Aplasia/Hypoplasia of the skin | 1.54e-04 | 201 | 22 | 6 | HP:0008065 | |
| HumanPheno | Abnormal urinary electrolyte concentration | 1.61e-04 | 126 | 22 | 5 | HP:0012591 | |
| HumanPheno | Bilateral ptosis | 1.88e-04 | 69 | 22 | 4 | HP:0001488 | |
| HumanPheno | Abnormal posterior cranial fossa morphology | 2.59e-04 | 221 | 22 | 6 | HP:0000932 | |
| HumanPheno | Angiofibromas | 2.63e-04 | 30 | 22 | 3 | HP:0010615 | |
| HumanPheno | Hyperphosphaturia | 2.63e-04 | 30 | 22 | 3 | HP:0003109 | |
| HumanPheno | Radial deviation of the 2nd finger | 2.64e-04 | 6 | 22 | 2 | HP:0009467 | |
| HumanPheno | Abnormal lymphocyte apoptosis | 2.64e-04 | 6 | 22 | 2 | HP:0030886 | |
| HumanPheno | Non-medullary thyroid carcinoma | 2.64e-04 | 6 | 22 | 2 | HP:0040198 | |
| HumanPheno | Decreased lymphocyte apoptosis | 2.64e-04 | 6 | 22 | 2 | HP:0002731 | |
| HumanPheno | Lymphedema | 2.73e-04 | 76 | 22 | 4 | HP:0001004 | |
| HumanPheno | Cone-shaped epiphyses of the phalanges of the hand | 2.91e-04 | 31 | 22 | 3 | HP:0010230 | |
| HumanPheno | Cavernous hemangioma | 2.91e-04 | 31 | 22 | 3 | HP:0001048 | |
| HumanPheno | Transitional cell carcinoma of the bladder | 2.91e-04 | 31 | 22 | 3 | HP:0006740 | |
| HumanPheno | Porencephalic cyst | 3.20e-04 | 32 | 22 | 3 | HP:0002132 | |
| HumanPheno | Phalangeal cone-shaped epiphyses | 3.20e-04 | 32 | 22 | 3 | HP:0034281 | |
| HumanPheno | Abnormal mitral valve morphology | 3.21e-04 | 146 | 22 | 5 | HP:0031477 | |
| HumanPheno | Abnormal morphology of the vestibule of the inner ear | 3.51e-04 | 33 | 22 | 3 | HP:0011376 | |
| HumanPheno | Bladder carcinoma | 3.51e-04 | 33 | 22 | 3 | HP:0002862 | |
| HumanPheno | Facial asymmetry | 3.52e-04 | 149 | 22 | 5 | HP:0000324 | |
| HumanPheno | Congenital giant melanocytic nevus | 3.69e-04 | 7 | 22 | 2 | HP:0005600 | |
| HumanPheno | Prominence of the premaxilla | 3.69e-04 | 7 | 22 | 2 | HP:0010759 | |
| HumanPheno | Full cheeks | 3.75e-04 | 151 | 22 | 5 | HP:0000293 | |
| HumanPheno | Genu recurvatum | 3.84e-04 | 34 | 22 | 3 | HP:0002816 | |
| HumanPheno | Abnormality of dental color | 3.84e-04 | 34 | 22 | 3 | HP:0011073 | |
| HumanPheno | Bladder neoplasm | 3.84e-04 | 34 | 22 | 3 | HP:0009725 | |
| HumanPheno | Congenital onset | KRAS GDF5 FLNA IFT140 DLG5 NRAS HRAS PDX1 LRP5 KIF5A TAF1 PLEC GFRA1 | 3.85e-04 | 1206 | 22 | 13 | HP:0003577 |
| HumanPheno | Abnormal urine phosphate concentration | 4.19e-04 | 35 | 22 | 3 | HP:0012599 | |
| HumanPheno | Abnormal skull base morphology | 4.24e-04 | 242 | 22 | 6 | HP:0002693 | |
| HumanPheno | Curly hair | 4.55e-04 | 36 | 22 | 3 | HP:0002212 | |
| HumanPheno | Overgrowth | 4.59e-04 | 87 | 22 | 4 | HP:0001548 | |
| HumanPheno | Abnormal knee physiology | 4.59e-04 | 87 | 22 | 4 | HP:0034670 | |
| HumanPheno | Hyperextensible skin | 5.19e-04 | 162 | 22 | 5 | HP:0000974 | |
| HumanPheno | Craniofacial hyperostosis | 5.35e-04 | 38 | 22 | 3 | HP:0004493 | |
| HumanPheno | Abnormal renal morphology | KRAS FLNA IFT140 DLG5 NRAS HRAS PDX1 LRP5 DAAM2 PLEC TNXB NDUFS3 GFRA1 | 5.71e-04 | 1252 | 22 | 13 | HP:0012210 |
| HumanPheno | Enlarged thorax | 6.17e-04 | 94 | 22 | 4 | HP:0100625 | |
| HumanPheno | Hyperextensibility of the knee | 6.23e-04 | 40 | 22 | 3 | HP:0010500 | |
| HumanPheno | Cerebellar malformation | 6.28e-04 | 487 | 22 | 8 | HP:0002438 | |
| HumanPheno | Alopecia | 6.36e-04 | 261 | 22 | 6 | HP:0001596 | |
| HumanPheno | Aplasia cutis congenita | 6.70e-04 | 41 | 22 | 3 | HP:0001057 | |
| HumanPheno | Nail dysplasia | 6.76e-04 | 264 | 22 | 6 | HP:0002164 | |
| HumanPheno | Abnormal epiphysis morphology of the phalanges of the hand | 7.20e-04 | 42 | 22 | 3 | HP:0005920 | |
| HumanPheno | Abnormal 2nd finger morphology | 7.72e-04 | 43 | 22 | 3 | HP:0004100 | |
| HumanPheno | Bruising susceptibility | 7.99e-04 | 178 | 22 | 5 | HP:0000978 | |
| HumanPheno | Abnormally lax or hyperextensible skin | 8.20e-04 | 179 | 22 | 5 | HP:0008067 | |
| HumanPheno | Megalencephaly | 8.26e-04 | 44 | 22 | 3 | HP:0001355 | |
| HumanPheno | Polycystic liver disease | 9.57e-04 | 11 | 22 | 2 | HP:0006557 | |
| HumanPheno | Fibular aplasia | 9.57e-04 | 11 | 22 | 2 | HP:0002990 | |
| HumanPheno | Numerous nevi | 9.57e-04 | 11 | 22 | 2 | HP:0001054 | |
| HumanPheno | Abnormal cheek morphology | 9.58e-04 | 282 | 22 | 6 | HP:0004426 | |
| HumanPheno | Thickened helices | 1.00e-03 | 47 | 22 | 3 | HP:0000391 | |
| HumanPheno | Abnormal urine anion concentration | 1.00e-03 | 47 | 22 | 3 | HP:0011866 | |
| HumanPheno | Rickets | 1.00e-03 | 47 | 22 | 3 | HP:0002748 | |
| HumanPheno | Abnormality of the pylorus | 1.01e-03 | 107 | 22 | 4 | HP:0004400 | |
| HumanPheno | Chiari malformation | 1.01e-03 | 107 | 22 | 4 | HP:0002308 | |
| HumanPheno | Sparse or absent hair | 1.04e-03 | 525 | 22 | 8 | HP:0002115 | |
| HumanPheno | Chiari type I malformation | 1.07e-03 | 48 | 22 | 3 | HP:0007099 | |
| HumanPheno | Autoimmune thrombocytopenia | 1.13e-03 | 49 | 22 | 3 | HP:0001973 | |
| HumanPheno | Abnormality of the premaxilla | 1.14e-03 | 12 | 22 | 2 | HP:0010758 | |
| HumanPheno | Abnormal bleeding | 1.21e-03 | 537 | 22 | 8 | HP:0001892 | |
| HumanPheno | Abnormal joint physiology | KRAS GDF5 FLNA DLG5 NRAS HRAS PDX1 LRP5 KIF5A TAF1 PLEC TNXB NDUFS3 | 1.32e-03 | 1358 | 22 | 13 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | KRAS GDF5 FLNA DLG5 NRAS HRAS PDX1 LRP5 KIF5A TAF1 PLEC TNXB NDUFS3 | 1.32e-03 | 1358 | 22 | 13 | HP:0011729 |
| HumanPheno | Hypophosphatemia | 1.42e-03 | 53 | 22 | 3 | HP:0002148 | |
| HumanPheno | Cranial hyperostosis | 1.42e-03 | 53 | 22 | 3 | HP:0004437 | |
| HumanPheno | Broad forehead | 1.51e-03 | 205 | 22 | 5 | HP:0000337 | |
| HumanPheno | Joint hypermobility | 1.54e-03 | 557 | 22 | 8 | HP:0001382 | |
| HumanPheno | Aplasia/Hypoplasia of the middle phalanx of the 2nd finger | 1.57e-03 | 14 | 22 | 2 | HP:0009568 | |
| HumanPheno | Abnormality of the middle phalanx of the 2nd finger | 1.57e-03 | 14 | 22 | 2 | HP:0009543 | |
| HumanPheno | Tricuspid valve prolapse | 1.57e-03 | 14 | 22 | 2 | HP:0001704 | |
| HumanPheno | Sarcoma | 1.68e-03 | 210 | 22 | 5 | HP:0100242 | |
| HumanPheno | Fibroma | 1.74e-03 | 124 | 22 | 4 | HP:0010614 | |
| HumanPheno | Monocytosis | 1.81e-03 | 15 | 22 | 2 | HP:0012311 | |
| HumanPheno | Multiple lentigines | 1.81e-03 | 15 | 22 | 2 | HP:0001003 | |
| HumanPheno | Follicular hyperplasia | 1.81e-03 | 15 | 22 | 2 | HP:0002729 | |
| HumanPheno | Fibrous tissue neoplasm | 1.85e-03 | 126 | 22 | 4 | HP:0012316 | |
| HumanPheno | Increased skull ossification | 1.85e-03 | 58 | 22 | 3 | HP:0004330 | |
| HumanPheno | Coarse hair | 1.85e-03 | 58 | 22 | 3 | HP:0002208 | |
| HumanPheno | Basal cell carcinoma | 1.85e-03 | 58 | 22 | 3 | HP:0002671 | |
| MousePheno | abnormal abdominal wall morphology | 4.46e-05 | 82 | 67 | 5 | MP:0003257 | |
| MousePheno | thick retina inner plexiform layer | 6.77e-05 | 3 | 67 | 2 | MP:0014265 | |
| MousePheno | spleen vascular congestion | 6.77e-05 | 3 | 67 | 2 | MP:0010020 | |
| MousePheno | abnormal body wall morphology | 8.34e-05 | 151 | 67 | 6 | MP:0003385 | |
| MousePheno | omphalocele | 1.18e-04 | 53 | 67 | 4 | MP:0003052 | |
| MousePheno | hypertension | 1.47e-04 | 56 | 67 | 4 | MP:0000231 | |
| Domain | Ig_E-set | 3.51e-06 | 104 | 74 | 6 | IPR014756 | |
| Domain | IPT | 1.63e-04 | 27 | 74 | 3 | SM00429 | |
| Domain | - | 2.30e-04 | 6 | 74 | 2 | 3.90.1290.10 | |
| Domain | Peptidase_S8_Asp-AS | 2.30e-04 | 6 | 74 | 2 | IPR023827 | |
| Domain | IPT | 2.73e-04 | 32 | 74 | 3 | IPR002909 | |
| Domain | Plectin_repeat | 3.21e-04 | 7 | 74 | 2 | IPR001101 | |
| Domain | PrprotnconvertsP | 3.21e-04 | 7 | 74 | 2 | IPR002884 | |
| Domain | Plectin | 3.21e-04 | 7 | 74 | 2 | PF00681 | |
| Domain | P_proprotein | 3.21e-04 | 7 | 74 | 2 | PF01483 | |
| Domain | S8_pro-domain | 3.21e-04 | 7 | 74 | 2 | IPR032815 | |
| Domain | - | 3.21e-04 | 7 | 74 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 3.21e-04 | 7 | 74 | 2 | PF16470 | |
| Domain | PLEC | 3.21e-04 | 7 | 74 | 2 | SM00250 | |
| Domain | RAS | 3.57e-04 | 35 | 74 | 3 | PS51421 | |
| Domain | Small_GTPase_Ras | 4.21e-04 | 37 | 74 | 3 | IPR020849 | |
| Domain | Peptidase_S8_His-AS | 5.48e-04 | 9 | 74 | 2 | IPR022398 | |
| Domain | Plexin_cytopl | 5.48e-04 | 9 | 74 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 5.48e-04 | 9 | 74 | 2 | IPR013548 | |
| Domain | Plexin | 5.48e-04 | 9 | 74 | 2 | IPR031148 | |
| Domain | Peptidase_S8_Ser-AS | 5.48e-04 | 9 | 74 | 2 | IPR023828 | |
| Domain | Peptidase_S8_subtilisin-rel | 6.83e-04 | 10 | 74 | 2 | IPR015500 | |
| Domain | SUBTILASE_ASP | 6.83e-04 | 10 | 74 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 6.83e-04 | 10 | 74 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 6.83e-04 | 10 | 74 | 2 | PS00138 | |
| Domain | - | 8.32e-04 | 11 | 74 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 8.32e-04 | 11 | 74 | 2 | IPR000209 | |
| Domain | GAIN_dom_N | 8.32e-04 | 11 | 74 | 2 | IPR032471 | |
| Domain | Peptidase_S8 | 8.32e-04 | 11 | 74 | 2 | PF00082 | |
| Domain | GAIN | 8.32e-04 | 11 | 74 | 2 | PF16489 | |
| Domain | Cadherin_CS | 9.23e-04 | 109 | 74 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 1.06e-03 | 113 | 74 | 4 | PS00232 | |
| Domain | Cadherin | 1.06e-03 | 113 | 74 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 1.09e-03 | 114 | 74 | 4 | PS50268 | |
| Domain | - | 1.09e-03 | 114 | 74 | 4 | 2.60.40.60 | |
| Domain | CA | 1.13e-03 | 115 | 74 | 4 | SM00112 | |
| Domain | Cadherin-like | 1.16e-03 | 116 | 74 | 4 | IPR015919 | |
| Domain | - | 1.20e-03 | 663 | 74 | 9 | 2.60.40.10 | |
| Domain | Cadherin | 1.24e-03 | 118 | 74 | 4 | IPR002126 | |
| Domain | EGF | 1.58e-03 | 126 | 74 | 4 | PF00008 | |
| Domain | Ig-like_fold | 1.84e-03 | 706 | 74 | 9 | IPR013783 | |
| Domain | Propept_inh | 2.03e-03 | 17 | 74 | 2 | IPR009020 | |
| Domain | CH | 2.19e-03 | 65 | 74 | 3 | SM00033 | |
| Domain | Furin_repeat | 2.27e-03 | 18 | 74 | 2 | IPR006212 | |
| Domain | FU | 2.27e-03 | 18 | 74 | 2 | SM00261 | |
| Domain | EGF | 2.41e-03 | 235 | 74 | 5 | SM00181 | |
| Domain | CH | 2.70e-03 | 70 | 74 | 3 | PF00307 | |
| Domain | - | 2.81e-03 | 71 | 74 | 3 | 1.10.418.10 | |
| Domain | CH | 3.04e-03 | 73 | 74 | 3 | PS50021 | |
| Domain | EGF-like_dom | 3.09e-03 | 249 | 74 | 5 | IPR000742 | |
| Domain | CH-domain | 3.29e-03 | 75 | 74 | 3 | IPR001715 | |
| Domain | Growth_fac_rcpt_ | 3.42e-03 | 156 | 74 | 4 | IPR009030 | |
| Domain | Actinin_actin-bd_CS | 3.71e-03 | 23 | 74 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 3.71e-03 | 23 | 74 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.71e-03 | 23 | 74 | 2 | PS00019 | |
| Domain | fn3 | 3.92e-03 | 162 | 74 | 4 | PF00041 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 7.29e-07 | 5 | 60 | 3 | M26921 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 1.45e-06 | 6 | 60 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 1.45e-06 | 6 | 60 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 1.45e-06 | 6 | 60 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 1.45e-06 | 6 | 60 | 3 | M47932 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 2.53e-06 | 7 | 60 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 2.53e-06 | 7 | 60 | 3 | M19489 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 4.04e-06 | 8 | 60 | 3 | M47935 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 4.04e-06 | 8 | 60 | 3 | M27919 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 6.05e-06 | 9 | 60 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 6.05e-06 | 9 | 60 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 6.05e-06 | 9 | 60 | 3 | M27904 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 1.18e-05 | 11 | 60 | 3 | M27740 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 1.18e-05 | 11 | 60 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.18e-05 | 11 | 60 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.18e-05 | 11 | 60 | 3 | M47371 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 1.18e-05 | 11 | 60 | 3 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 1.18e-05 | 11 | 60 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 1.18e-05 | 11 | 60 | 3 | M47432 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 1.18e-05 | 11 | 60 | 3 | M27911 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.57e-05 | 12 | 60 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 1.57e-05 | 12 | 60 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 1.57e-05 | 12 | 60 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 1.57e-05 | 12 | 60 | 3 | M39408 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 2.03e-05 | 13 | 60 | 3 | M47594 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 2.03e-05 | 13 | 60 | 3 | M1441 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 2.58e-05 | 14 | 60 | 3 | M27734 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.58e-05 | 14 | 60 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 2.58e-05 | 14 | 60 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 2.58e-05 | 14 | 60 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 2.58e-05 | 14 | 60 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.58e-05 | 14 | 60 | 3 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 2.58e-05 | 14 | 60 | 3 | M569 | |
| Pathway | PID_TCR_RAS_PATHWAY | 2.58e-05 | 14 | 60 | 3 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 2.58e-05 | 14 | 60 | 3 | M47488 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 2.58e-05 | 14 | 60 | 3 | M27908 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 2.58e-05 | 14 | 60 | 3 | M719 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 3.22e-05 | 15 | 60 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.22e-05 | 15 | 60 | 3 | M47531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.95e-05 | 16 | 60 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 3.95e-05 | 16 | 60 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 3.95e-05 | 16 | 60 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 3.95e-05 | 16 | 60 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 3.95e-05 | 16 | 60 | 3 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 3.95e-05 | 16 | 60 | 3 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 3.95e-05 | 16 | 60 | 3 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 3.95e-05 | 16 | 60 | 3 | M47483 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 3.95e-05 | 16 | 60 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 3.95e-05 | 16 | 60 | 3 | M47682 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 4.23e-05 | 46 | 60 | 4 | M39828 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 4.78e-05 | 17 | 60 | 3 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 4.78e-05 | 17 | 60 | 3 | M47684 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 4.78e-05 | 17 | 60 | 3 | M27918 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 5.72e-05 | 18 | 60 | 3 | M27518 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 5.72e-05 | 18 | 60 | 3 | M39737 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 5.72e-05 | 18 | 60 | 3 | M657 | |
| Pathway | REACTOME_TIE2_SIGNALING | 5.72e-05 | 18 | 60 | 3 | M11932 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 6.77e-05 | 19 | 60 | 3 | M47793 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 6.77e-05 | 19 | 60 | 3 | M559 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 6.77e-05 | 19 | 60 | 3 | M27423 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 6.77e-05 | 19 | 60 | 3 | M41732 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 7.43e-05 | 53 | 60 | 4 | M27039 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 7.94e-05 | 20 | 60 | 3 | M12256 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 7.94e-05 | 20 | 60 | 3 | M27519 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 7.94e-05 | 20 | 60 | 3 | M27524 | |
| Pathway | WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING | 7.94e-05 | 20 | 60 | 3 | M39485 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE | 7.94e-05 | 20 | 60 | 3 | M29849 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 7.94e-05 | 20 | 60 | 3 | M17670 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 7.94e-05 | 20 | 60 | 3 | M39002 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 9.23e-05 | 21 | 60 | 3 | M27511 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 9.23e-05 | 21 | 60 | 3 | M47792 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 9.23e-05 | 21 | 60 | 3 | M27485 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.06e-04 | 58 | 60 | 4 | M2049 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 1.07e-04 | 22 | 60 | 3 | M27522 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 1.07e-04 | 22 | 60 | 3 | M26929 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.15e-04 | 261 | 60 | 7 | MM15676 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR1_SIGNALING | 1.22e-04 | 23 | 60 | 3 | M27513 | |
| Pathway | KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY | 1.22e-04 | 23 | 60 | 3 | M47799 | |
| Pathway | REACTOME_RAS_PROCESSING | 1.39e-04 | 24 | 60 | 3 | M38995 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.46e-04 | 63 | 60 | 4 | M11187 | |
| Pathway | PID_TCR_PATHWAY | 1.56e-04 | 64 | 60 | 4 | M34 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 1.58e-04 | 25 | 60 | 3 | M27517 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 1.58e-04 | 25 | 60 | 3 | M39794 | |
| Pubmed | 7.33e-10 | 7 | 76 | 4 | 20179099 | ||
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 1.00e-08 | 3 | 76 | 3 | 28116986 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 1.00e-08 | 3 | 76 | 3 | 37013448 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 1.00e-08 | 3 | 76 | 3 | 19101897 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 25977330 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 33620658 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 1.00e-08 | 3 | 76 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 1.00e-08 | 3 | 76 | 3 | 7776260 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 1.00e-08 | 3 | 76 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 1.00e-08 | 3 | 76 | 3 | 26253102 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 16573741 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 25788415 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 1.00e-08 | 3 | 76 | 3 | 20090846 | |
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 1.00e-08 | 3 | 76 | 3 | 26799184 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 21737741 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 1.00e-08 | 3 | 76 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 1.00e-08 | 3 | 76 | 3 | 23240926 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 17943694 | ||
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 1.00e-08 | 3 | 76 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 1.00e-08 | 3 | 76 | 3 | 17712732 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 24222113 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 1.00e-08 | 3 | 76 | 3 | 16761621 | |
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 1.00e-08 | 3 | 76 | 3 | 22945650 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 19303097 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 1.00e-08 | 3 | 76 | 3 | 20150643 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 20971740 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 27119512 | ||
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 1.00e-08 | 3 | 76 | 3 | 9334313 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCSK5 PLXNA3 FLNA KIAA0930 EPPK1 ABR CELSR3 CELSR2 FURIN NFKB2 LRP5 TLN2 MICAL3 FAM110A PLEC | 1.43e-08 | 1105 | 76 | 15 | 35748872 |
| Pubmed | CDMP1/GDF5 has specific processing requirements that restrict its action to joint surfaces. | 4.00e-08 | 4 | 76 | 3 | 16829522 | |
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 4.00e-08 | 4 | 76 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 4.00e-08 | 4 | 76 | 3 | 29502968 | |
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 4.00e-08 | 4 | 76 | 3 | 7972015 | |
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 10490827 | ||
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 4.00e-08 | 4 | 76 | 3 | 25999467 | |
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 10085069 | ||
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 38849523 | ||
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 34948093 | ||
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 9674433 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 4.00e-08 | 4 | 76 | 3 | 20080631 | |
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 4.00e-08 | 4 | 76 | 3 | 28117393 | |
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 22982107 | ||
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 1.00e-07 | 5 | 76 | 3 | 34535655 | |
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 9069260 | ||
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 1.00e-07 | 5 | 76 | 3 | 24746824 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 1.00e-07 | 5 | 76 | 3 | 15558479 | |
| Pubmed | 2.00e-07 | 6 | 76 | 3 | 9753431 | ||
| Pubmed | 2.00e-07 | 6 | 76 | 3 | 21072204 | ||
| Pubmed | 2.00e-07 | 6 | 76 | 3 | 10882715 | ||
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 2.00e-07 | 6 | 76 | 3 | 29615452 | |
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 2.00e-07 | 6 | 76 | 3 | 31337872 | |
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 19487299 | ||
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 20526288 | ||
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 20012784 | ||
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 9690470 | ||
| Pubmed | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | 3.49e-07 | 7 | 76 | 3 | 35904492 | |
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 3.49e-07 | 7 | 76 | 3 | 11948427 | |
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 20860430 | ||
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 22199277 | ||
| Pubmed | 5.57e-07 | 8 | 76 | 3 | 15064703 | ||
| Pubmed | Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. | 5.57e-07 | 8 | 76 | 3 | 20150892 | |
| Pubmed | 8.34e-07 | 9 | 76 | 3 | 9344703 | ||
| Pubmed | 8.34e-07 | 9 | 76 | 3 | 10783161 | ||
| Pubmed | 1.19e-06 | 10 | 76 | 3 | 34215617 | ||
| Pubmed | Desmoplakin maintains gap junctions by inhibiting Ras/MAPK and lysosomal degradation of connexin-43. | 1.19e-06 | 10 | 76 | 3 | 29959233 | |
| Pubmed | SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. | 1.63e-06 | 11 | 76 | 3 | 28263956 | |
| Pubmed | 2.17e-06 | 12 | 76 | 3 | 9269777 | ||
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 2.17e-06 | 12 | 76 | 3 | 9297626 | |
| Pubmed | Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. | 2.82e-06 | 13 | 76 | 3 | 22723296 | |
| Pubmed | 3.59e-06 | 14 | 76 | 3 | 25359213 | ||
| Pubmed | 4.48e-06 | 15 | 76 | 3 | 23831572 | ||
| Pubmed | The Ras branch of small GTPases: Ras family members don't fall far from the tree. | 4.48e-06 | 15 | 76 | 3 | 10712923 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19789336 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16624289 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27698462 | ||
| Pubmed | Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck. | 4.71e-06 | 2 | 76 | 2 | 31960612 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 1970154 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20188103 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33053566 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33544116 | ||
| Pubmed | Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents. | 4.71e-06 | 2 | 76 | 2 | 14688017 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20371679 | ||
| Pubmed | The prominent pervasive oncogenic role and tissue specific permissiveness of RAS gene mutations. | 4.71e-06 | 2 | 76 | 2 | 39455841 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26049686 | ||
| Pubmed | Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients. | 4.71e-06 | 2 | 76 | 2 | 29921458 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28939768 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17499243 | ||
| Pubmed | Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia. | 4.71e-06 | 2 | 76 | 2 | 24737308 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17210246 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 39273371 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25009008 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28859058 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25227306 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28703285 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17332249 | ||
| Interaction | ITGB6 interactions | 1.82e-07 | 14 | 76 | 4 | int:ITGB6 | |
| Interaction | DKKL1 interactions | 2.03e-07 | 111 | 76 | 7 | int:DKKL1 | |
| Interaction | HEPH interactions | 1.02e-06 | 6 | 76 | 3 | int:HEPH | |
| Interaction | PLCD1 interactions | 2.19e-06 | 56 | 76 | 5 | int:PLCD1 | |
| Interaction | TRPV2 interactions | 6.07e-06 | 10 | 76 | 3 | int:TRPV2 | |
| Interaction | ANK3 interactions | 1.08e-05 | 201 | 76 | 7 | int:ANK3 | |
| Interaction | GTSF1 interactions | 1.11e-05 | 12 | 76 | 3 | int:GTSF1 | |
| Interaction | EPS8 interactions | 1.25e-05 | 136 | 76 | 6 | int:EPS8 | |
| Interaction | CDC42BPA interactions | 1.88e-05 | 146 | 76 | 6 | int:CDC42BPA | |
| Interaction | SFT2D1 interactions | 2.06e-05 | 43 | 76 | 4 | int:SFT2D1 | |
| Interaction | SNRNP40 interactions | KRAS FLNA DDX17 PRPF40B CWC15 ZC3H13 ATAD2B ZNF318 SREK1 MGA ATXN1L | 2.56e-05 | 637 | 76 | 11 | int:SNRNP40 |
| Interaction | AURKB interactions | KRAS FLNA DLG5 EPPK1 DDX17 NRAS ABR BYSL TAF1 PLEC NDUFS3 XRCC6 | 2.60e-05 | 761 | 76 | 12 | int:AURKB |
| Interaction | TOP3B interactions | PCSK5 PLXNA3 FLNA KIAA0930 EPPK1 ABR CELSR3 CELSR2 FURIN NFKB2 BYSL LRP5 TLN2 MICAL3 FAM110A PLEC XRCC6 | 2.62e-05 | 1470 | 76 | 17 | int:TOP3B |
| Interaction | ELMOD3 interactions | 2.79e-05 | 16 | 76 | 3 | int:ELMOD3 | |
| Interaction | SAMSN1 interactions | 2.79e-05 | 16 | 76 | 3 | int:SAMSN1 | |
| Interaction | SPTA1 interactions | 2.82e-05 | 94 | 76 | 5 | int:SPTA1 | |
| Interaction | AFDN interactions | 3.63e-05 | 333 | 76 | 8 | int:AFDN | |
| Interaction | NCAM1 interactions | 3.99e-05 | 101 | 76 | 5 | int:NCAM1 | |
| Interaction | KRT8 interactions | 4.13e-05 | 441 | 76 | 9 | int:KRT8 | |
| Interaction | METTL14 interactions | KRAS FLNA ERICH3 DDX17 CELSR3 ZC3H13 MAP3K15 KIF5A PLEC XRCC6 | 4.52e-05 | 558 | 76 | 10 | int:METTL14 |
| Interaction | NOTCH1 interactions | 4.66e-05 | 345 | 76 | 8 | int:NOTCH1 | |
| Interaction | SHISA2 interactions | 4.78e-05 | 19 | 76 | 3 | int:SHISA2 | |
| Interaction | GYPC interactions | 4.78e-05 | 19 | 76 | 3 | int:GYPC | |
| Interaction | STMN3 interactions | 5.50e-05 | 55 | 76 | 4 | int:STMN3 | |
| Interaction | SLC6A9 interactions | 5.61e-05 | 20 | 76 | 3 | int:SLC6A9 | |
| Interaction | SUSD5 interactions | 5.61e-05 | 20 | 76 | 3 | int:SUSD5 | |
| Interaction | LHX3 interactions | 7.08e-05 | 185 | 76 | 6 | int:LHX3 | |
| Interaction | PIK3CG interactions | 7.26e-05 | 59 | 76 | 4 | int:PIK3CG | |
| Interaction | NECTIN1 interactions | 7.54e-05 | 22 | 76 | 3 | int:NECTIN1 | |
| Interaction | ALKBH3 interactions | 8.28e-05 | 61 | 76 | 4 | int:ALKBH3 | |
| Interaction | GAL3ST4 interactions | 8.38e-05 | 4 | 76 | 2 | int:GAL3ST4 | |
| Interaction | CHMP4B interactions | KRAS FLNA TAF8 EPPK1 DDX17 CD109 TLN2 TAF1 PLEC XRCC6 FAM83B | 8.45e-05 | 727 | 76 | 11 | int:CHMP4B |
| Interaction | SEMA6D interactions | 8.65e-05 | 23 | 76 | 3 | int:SEMA6D | |
| Interaction | SLC23A2 interactions | 8.65e-05 | 23 | 76 | 3 | int:SLC23A2 | |
| Interaction | DEPDC1B interactions | 8.69e-05 | 192 | 76 | 6 | int:DEPDC1B | |
| Interaction | SEMA6A interactions | 9.40e-05 | 63 | 76 | 4 | int:SEMA6A | |
| Interaction | WDR76 interactions | 9.67e-05 | 383 | 76 | 8 | int:WDR76 | |
| Interaction | CLDN3 interactions | 9.85e-05 | 24 | 76 | 3 | int:CLDN3 | |
| Interaction | TAOK3 interactions | 1.00e-04 | 64 | 76 | 4 | int:TAOK3 | |
| Interaction | IL5RA interactions | 1.06e-04 | 124 | 76 | 5 | int:IL5RA | |
| Interaction | ROR1 interactions | 1.14e-04 | 126 | 76 | 5 | int:ROR1 | |
| Interaction | CLDN1 interactions | 1.26e-04 | 26 | 76 | 3 | int:CLDN1 | |
| Interaction | SLITRK2 interactions | 1.39e-04 | 5 | 76 | 2 | int:SLITRK2 | |
| Interaction | PDLIM4 interactions | 1.41e-04 | 27 | 76 | 3 | int:PDLIM4 | |
| Interaction | SAP18 interactions | 1.52e-04 | 305 | 76 | 7 | int:SAP18 | |
| Interaction | RGL2 interactions | 1.58e-04 | 28 | 76 | 3 | int:RGL2 | |
| Interaction | PTPRM interactions | 1.58e-04 | 72 | 76 | 4 | int:PTPRM | |
| Interaction | SLC7A5 interactions | 1.61e-04 | 215 | 76 | 6 | int:SLC7A5 | |
| Interaction | DCUN1D3 interactions | 1.75e-04 | 29 | 76 | 3 | int:DCUN1D3 | |
| Interaction | SLC35A2 interactions | 1.75e-04 | 29 | 76 | 3 | int:SLC35A2 | |
| Interaction | SPTBN1 interactions | 1.85e-04 | 421 | 76 | 8 | int:SPTBN1 | |
| Interaction | SLC1A4 interactions | 1.94e-04 | 30 | 76 | 3 | int:SLC1A4 | |
| Interaction | CD276 interactions | 1.94e-04 | 30 | 76 | 3 | int:CD276 | |
| Interaction | DCBLD1 interactions | 2.15e-04 | 31 | 76 | 3 | int:DCBLD1 | |
| Interaction | JAM3 interactions | 2.15e-04 | 31 | 76 | 3 | int:JAM3 | |
| Interaction | BTK interactions | 2.21e-04 | 145 | 76 | 5 | int:BTK | |
| Interaction | MEAK7 interactions | 2.36e-04 | 32 | 76 | 3 | int:MEAK7 | |
| Interaction | CHMP6 interactions | 2.59e-04 | 33 | 76 | 3 | int:CHMP6 | |
| Interaction | ST8SIA4 interactions | 2.87e-04 | 84 | 76 | 4 | int:ST8SIA4 | |
| Interaction | CIT interactions | FLNA EPPK1 DDX17 CELSR2 DSCAM CWC15 ZC3H13 CD109 BYSL SREK1 PLEC MMP15 CCDC180 NDUFS3 XRCC6 | 2.91e-04 | 1450 | 76 | 15 | int:CIT |
| Interaction | SEMA5A interactions | 2.91e-04 | 7 | 76 | 2 | int:SEMA5A | |
| Interaction | LRRC57 interactions | 3.09e-04 | 35 | 76 | 3 | int:LRRC57 | |
| Interaction | SLC2A3 interactions | 3.09e-04 | 35 | 76 | 3 | int:SLC2A3 | |
| Interaction | SEMA4D interactions | 3.09e-04 | 35 | 76 | 3 | int:SEMA4D | |
| Interaction | ITGA6 interactions | 3.09e-04 | 156 | 76 | 5 | int:ITGA6 | |
| Interaction | MBD5 interactions | 3.14e-04 | 86 | 76 | 4 | int:MBD5 | |
| Interaction | SIRPD interactions | 3.14e-04 | 86 | 76 | 4 | int:SIRPD | |
| Interaction | ZDHHC20 interactions | 3.36e-04 | 36 | 76 | 3 | int:ZDHHC20 | |
| Interaction | FAM83F interactions | 3.36e-04 | 36 | 76 | 3 | int:FAM83F | |
| Interaction | CEP104 interactions | 3.58e-04 | 89 | 76 | 4 | int:CEP104 | |
| Interaction | GAN interactions | 3.87e-04 | 253 | 76 | 6 | int:GAN | |
| Interaction | C2orf72 interactions | 3.87e-04 | 8 | 76 | 2 | int:C2orf72 | |
| Interaction | SSX6P interactions | 3.87e-04 | 8 | 76 | 2 | int:SSX6P | |
| Interaction | MAP4K4 interactions | 3.95e-04 | 254 | 76 | 6 | int:MAP4K4 | |
| Interaction | TTC4 interactions | 4.00e-04 | 165 | 76 | 5 | int:TTC4 | |
| Interaction | RASA1 interactions | 4.23e-04 | 167 | 76 | 5 | int:RASA1 | |
| Interaction | ATP7A interactions | 4.23e-04 | 93 | 76 | 4 | int:ATP7A | |
| Interaction | ADD2 interactions | 4.23e-04 | 93 | 76 | 4 | int:ADD2 | |
| Interaction | PCDH9 interactions | 4.27e-04 | 39 | 76 | 3 | int:PCDH9 | |
| Interaction | KIF23 interactions | KRAS FLNA DLG5 EPPK1 DDX17 ZC3H13 CD109 MICAL3 PLEC NDUFS3 XRCC6 FAM83B | 4.52e-04 | 1031 | 76 | 12 | int:KIF23 |
| Interaction | NDRG3 interactions | 4.61e-04 | 40 | 76 | 3 | int:NDRG3 | |
| Interaction | TRPM4 interactions | 4.61e-04 | 40 | 76 | 3 | int:TRPM4 | |
| Interaction | ECT2 interactions | FLNA EPPK1 DDX17 ABR CD109 BYSL MICAL3 SREK1 PLEC XRCC6 FAM83B | 4.72e-04 | 887 | 76 | 11 | int:ECT2 |
| Interaction | ROBO1 interactions | 4.77e-04 | 96 | 76 | 4 | int:ROBO1 | |
| Interaction | SIGLEC6 interactions | 4.97e-04 | 9 | 76 | 2 | int:SIGLEC6 | |
| Interaction | CAVIN4 interactions | 4.97e-04 | 9 | 76 | 2 | int:CAVIN4 | |
| Interaction | MYH9 interactions | KRAS FLNA PPP1R12B LTN1 CD109 CASP4 MICAL3 PLEC CCDC180 XRCC6 | 5.19e-04 | 754 | 76 | 10 | int:MYH9 |
| Interaction | MTMR10 interactions | 5.32e-04 | 42 | 76 | 3 | int:MTMR10 | |
| Interaction | MITD1 interactions | 5.32e-04 | 42 | 76 | 3 | int:MITD1 | |
| Interaction | NUP210P1 interactions | 5.32e-04 | 42 | 76 | 3 | int:NUP210P1 | |
| Interaction | DEFB135 interactions | 5.32e-04 | 42 | 76 | 3 | int:DEFB135 | |
| Interaction | CELSR2 interactions | 5.57e-04 | 100 | 76 | 4 | int:CELSR2 | |
| Interaction | SIRPA interactions | 5.57e-04 | 100 | 76 | 4 | int:SIRPA | |
| Interaction | NUP43 interactions | 5.60e-04 | 625 | 76 | 9 | int:NUP43 | |
| Interaction | NAV2 interactions | 5.71e-04 | 43 | 76 | 3 | int:NAV2 | |
| Interaction | PPFIBP2 interactions | 5.71e-04 | 43 | 76 | 3 | int:PPFIBP2 | |
| Interaction | TRIM37 interactions | 5.93e-04 | 630 | 76 | 9 | int:TRIM37 | |
| Interaction | DSCAML1 interactions | 6.19e-04 | 10 | 76 | 2 | int:DSCAML1 | |
| Interaction | ZBTB12 interactions | 6.19e-04 | 10 | 76 | 2 | int:ZBTB12 | |
| Interaction | ARPC3 interactions | 6.41e-04 | 183 | 76 | 5 | int:ARPC3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 1.92e-04 | 503 | 76 | 6 | chr6p21 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 2.82e-05 | 3 | 56 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 2.82e-05 | 3 | 56 | 2 | 1189 | |
| GeneFamily | RAS type GTPase family | 1.19e-04 | 31 | 56 | 3 | 389 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.61e-04 | 8 | 56 | 2 | 939 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 3.35e-04 | 9 | 56 | 2 | 973 | |
| GeneFamily | Plexins | 3.35e-04 | 9 | 56 | 2 | 683 | |
| GeneFamily | Fibronectin type III domain containing | 1.52e-03 | 160 | 56 | 4 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 3.00e-03 | 193 | 56 | 4 | 594 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-07 | 176 | 76 | 6 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-07 | 176 | 76 | 6 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | droplet-Bladder-Unstain-18m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 196 | 76 | 6 | 0d040ae2ce8a0e1a59145a9b9eaa979239c477ff | |
| ToppCell | droplet-Bladder-Unstain|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 196 | 76 | 6 | f240056e63aca02f25ea29bc9d34eedcf0f1c811 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 199 | 76 | 6 | a3ec743b978ba8fdf1677b4971b5731f50ddd30f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.17e-06 | 199 | 76 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.21e-06 | 200 | 76 | 6 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.21e-06 | 200 | 76 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 177 | 76 | 5 | 0417460bdb012bc43d7254377fa53d79cdab3f34 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 183 | 76 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 183 | 76 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-05 | 191 | 76 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-05 | 191 | 76 | 5 | 6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 192 | 76 | 5 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 193 | 76 | 5 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 193 | 76 | 5 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 195 | 76 | 5 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 196 | 76 | 5 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 196 | 76 | 5 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 196 | 76 | 5 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 196 | 76 | 5 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 196 | 76 | 5 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 197 | 76 | 5 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 197 | 76 | 5 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.20e-05 | 197 | 76 | 5 | 83a4b79fbfa1cf63441dee4424c3b87c988287bf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 198 | 76 | 5 | b027a141ab531d0f5d6a26811a53427e7b0771dd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 198 | 76 | 5 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 198 | 76 | 5 | 953630dbe3154b1b102b87de0feca2cbf124eabe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 198 | 76 | 5 | 8e45551224fbb30c0658ad47dd98335ecf165437 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.30e-05 | 199 | 76 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 199 | 76 | 5 | 9b02acae6325b0ac9642438a4431285ff396e5fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.30e-05 | 199 | 76 | 5 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.30e-05 | 199 | 76 | 5 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.36e-05 | 200 | 76 | 5 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-05 | 200 | 76 | 5 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.36e-05 | 200 | 76 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Nxph1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.68e-05 | 122 | 76 | 4 | dba1c647172a11381efcb178a23808161908daa3 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.49e-05 | 131 | 76 | 4 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.49e-05 | 131 | 76 | 4 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Crh|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.66e-05 | 136 | 76 | 4 | 44f03e4f55fb2c5f8b9397142c89f7194b009cc6 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.68e-05 | 140 | 76 | 4 | 17005ca714ba03d7528fe7979ffb4654a46b666c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.95e-05 | 141 | 76 | 4 | 5ef3166c5271aa90fd0633016edfe2c74b835319 | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 153 | 76 | 4 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-04 | 159 | 76 | 4 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.62e-04 | 160 | 76 | 4 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.74e-04 | 163 | 76 | 4 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 164 | 76 | 4 | 57301178e420983c0cb72178e288a3a0449fdda3 | |
| ToppCell | Severe-CD8+_T|World / Disease group and Cell class | 1.79e-04 | 64 | 76 | 3 | 3e7ede6ec5d8b9c4fc6f3aa8fda91fd9b763ef18 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 165 | 76 | 4 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-04 | 167 | 76 | 4 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 168 | 76 | 4 | ca65321259711321c175ede67bd67a47aad81d7a | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 2.00e-04 | 169 | 76 | 4 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-04 | 175 | 76 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-04 | 176 | 76 | 4 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-04 | 176 | 76 | 4 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 178 | 76 | 4 | 93ce73f8bcec63ebf86fabb546f88400e8f06465 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 178 | 76 | 4 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-04 | 179 | 76 | 4 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-04 | 179 | 76 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-04 | 180 | 76 | 4 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.54e-04 | 180 | 76 | 4 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-04 | 181 | 76 | 4 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-04 | 182 | 76 | 4 | 7b86703559438e2d5ef3dad963ee0d772513f313 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 184 | 76 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 184 | 76 | 4 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 184 | 76 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 184 | 76 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 184 | 76 | 4 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 184 | 76 | 4 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 185 | 76 | 4 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 185 | 76 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 185 | 76 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.88e-04 | 186 | 76 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 187 | 76 | 4 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-04 | 187 | 76 | 4 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-04 | 187 | 76 | 4 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-04 | 187 | 76 | 4 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 187 | 76 | 4 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 2.94e-04 | 187 | 76 | 4 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.94e-04 | 187 | 76 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.00e-04 | 188 | 76 | 4 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-04 | 188 | 76 | 4 | c2c51c6526defe2600302901159b8abbb58d7595 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-04 | 188 | 76 | 4 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 189 | 76 | 4 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 189 | 76 | 4 | 2ce330d8078833c05775c481e73770f9ee4a5c88 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-04 | 189 | 76 | 4 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | facs-Lung-24m-Epithelial-airway_epithelial-lung_ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 189 | 76 | 4 | 1c28ad1263891d963e483b6847d8e89cc1b2d07e | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-04 | 189 | 76 | 4 | feedac2751ed770f80bc56fec31662b5b3826f58 | |
| ToppCell | facs-Lung-24m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 189 | 76 | 4 | 00b20c2ed7876486c8e42e3a5b13023f44987a34 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 189 | 76 | 4 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 189 | 76 | 4 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 189 | 76 | 4 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 189 | 76 | 4 | 473c87036e04a058b4a5138438b7ba7e1e766799 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-04 | 189 | 76 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| Drug | L 744832 | 1.43e-07 | 4 | 76 | 3 | ctd:C096898 | |
| Drug | AC1L32OA | 2.96e-06 | 9 | 76 | 3 | CID000107745 | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.76e-06 | 193 | 76 | 7 | 1644_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 3.89e-06 | 194 | 76 | 7 | 2684_DN | |
| Drug | isoprene | 1.10e-05 | 2 | 76 | 2 | ctd:C005059 | |
| Drug | Tetranitromethane | 3.29e-05 | 3 | 76 | 2 | ctd:D013774 | |
| Drug | GGTI 2147 | 3.29e-05 | 3 | 76 | 2 | ctd:C466792 | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 4.72e-05 | 194 | 76 | 6 | 6195_UP | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 7027_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 5232_UP | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 4101_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 5.14e-05 | 197 | 76 | 6 | 3180_DN | |
| Drug | Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 7430_UP | |
| Drug | Sulmazole [73384-60-8]; Up 200; 14uM; HL60; HT_HG-U133A | 5.44e-05 | 199 | 76 | 6 | 2153_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 5.44e-05 | 199 | 76 | 6 | 3128_DN | |
| Drug | Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; PC3; HT_HG-U133A | 5.59e-05 | 200 | 76 | 6 | 2082_UP | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; HL60; HT_HG-U133A | 5.59e-05 | 200 | 76 | 6 | 3036_DN | |
| Drug | helium;dihydroiodide | 6.03e-05 | 23 | 76 | 3 | CID000437954 | |
| Disease | Verrucous epidermal nevus | 1.64e-08 | 3 | 76 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 1.64e-08 | 3 | 76 | 3 | C4552097 | |
| Disease | Organoid Nevus Phakomatosis | 1.64e-08 | 3 | 76 | 3 | C0265329 | |
| Disease | Linear nevus sebaceous syndrome | 1.64e-08 | 3 | 76 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 1.64e-08 | 3 | 76 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 1.64e-08 | 3 | 76 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 1.64e-08 | 3 | 76 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 1.64e-08 | 3 | 76 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 1.64e-08 | 3 | 76 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Linear Verrucous Epidermal Nevus | 1.64e-08 | 3 | 76 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 1.64e-08 | 3 | 76 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL (disorder) | 1.64e-07 | 5 | 76 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 1.64e-07 | 5 | 76 | 3 | C0206682 | |
| Disease | Hemimegalencephaly | 3.27e-07 | 6 | 76 | 3 | C0431391 | |
| Disease | RASopathy (implicated_via_orthology) | 1.36e-06 | 9 | 76 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Noonan Syndrome 1 | 2.67e-06 | 11 | 76 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 2.67e-06 | 11 | 76 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 2.67e-06 | 11 | 76 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 2.67e-06 | 11 | 76 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 2.81e-06 | 38 | 76 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 5.05e-06 | 96 | 76 | 5 | C1319315 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 6.55e-06 | 2 | 76 | 2 | 614470 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 6.55e-06 | 2 | 76 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 6.55e-06 | 2 | 76 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 6.55e-06 | 2 | 76 | 2 | 137550 | |
| Disease | Melanocytic nevus | 6.55e-06 | 2 | 76 | 2 | cv:C0027962 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 6.55e-06 | 2 | 76 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 6.55e-06 | 2 | 76 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Large congenital melanocytic nevus | 6.55e-06 | 2 | 76 | 2 | cv:C1842036 | |
| Disease | RASopathy | 7.31e-06 | 15 | 76 | 3 | cv:C5555857 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 1.54e-05 | 19 | 76 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 1.54e-05 | 19 | 76 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 1.54e-05 | 19 | 76 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 1.54e-05 | 19 | 76 | 3 | C0587248 | |
| Disease | leukemia (implicated_via_orthology) | 1.54e-05 | 19 | 76 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 1.96e-05 | 3 | 76 | 2 | C1842036 | |
| Disease | LEOPARD Syndrome | 2.44e-05 | 22 | 76 | 3 | C0175704 | |
| Disease | Noonan Syndrome | 3.20e-05 | 24 | 76 | 3 | C0028326 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.46e-05 | 71 | 76 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL | 3.92e-05 | 4 | 76 | 2 | 162900 | |
| Disease | Malignant neoplasm of penis | 3.92e-05 | 4 | 76 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 3.92e-05 | 4 | 76 | 2 | C0030849 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 3.92e-05 | 4 | 76 | 2 | C4011754 | |
| Disease | BLADDER CANCER | 3.92e-05 | 4 | 76 | 2 | 109800 | |
| Disease | Epidermal nevus | 3.92e-05 | 4 | 76 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 3.92e-05 | 4 | 76 | 2 | cv:C0005684 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 3.92e-05 | 4 | 76 | 2 | cv:C4225426 | |
| Disease | Malignant tumor of cervix | 3.92e-05 | 4 | 76 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 3.92e-05 | 4 | 76 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 3.92e-05 | 4 | 76 | 2 | 188470 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 5.72e-05 | 29 | 76 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 6.34e-05 | 30 | 76 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 6.51e-05 | 5 | 76 | 2 | C4225426 | |
| Disease | Malignant neoplasm of thyroid | 6.51e-05 | 5 | 76 | 2 | C0007115 | |
| Disease | Cetuximab response | 6.51e-05 | 5 | 76 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 6.51e-05 | 5 | 76 | 2 | C0302592 | |
| Disease | Panitumumab response | 6.51e-05 | 5 | 76 | 2 | cv:CN077999 | |
| Disease | intestinal cancer (implicated_via_orthology) | 7.72e-05 | 32 | 76 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 8.47e-05 | 33 | 76 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | Pleocytosis | 9.75e-05 | 6 | 76 | 2 | C0151857 | |
| Disease | Autoimmune lymphoproliferative syndrome | 9.75e-05 | 6 | 76 | 2 | cv:CN301239 | |
| Disease | Carcinoma in situ of uterine cervix | 9.75e-05 | 6 | 76 | 2 | C0851140 | |
| Disease | seminoma (is_implicated_in) | 9.75e-05 | 6 | 76 | 2 | DOID:4440 (is_implicated_in) | |
| Disease | Leukocytosis | 9.75e-05 | 6 | 76 | 2 | C0023518 | |
| Disease | Thyroid Neoplasm | 1.20e-04 | 37 | 76 | 3 | C0040136 | |
| Disease | Thyroid cancer, follicular | 1.36e-04 | 7 | 76 | 2 | C2931367 | |
| Disease | Alzheimer's disease biomarker measurement, brain volume measurement | 1.81e-04 | 8 | 76 | 2 | EFO_0006514, EFO_0006930 | |
| Disease | gdnf family receptor alpha-1 measurement | 1.81e-04 | 8 | 76 | 2 | EFO_0020400 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.95e-04 | 206 | 76 | 5 | C0152013 | |
| Disease | high grade glioma (implicated_via_orthology) | 2.02e-04 | 44 | 76 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Thyroid carcinoma | 2.02e-04 | 44 | 76 | 3 | C0549473 | |
| Disease | Noonan syndrome | 2.33e-04 | 9 | 76 | 2 | cv:C0028326 | |
| Disease | Neuroblastoma | 2.45e-04 | 47 | 76 | 3 | C0027819 | |
| Disease | Alzheimer's disease biomarker measurement | 2.61e-04 | 48 | 76 | 3 | EFO_0006514 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 2.91e-04 | 10 | 76 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | entorhinal cortical volume, Alzheimer's disease biomarker measurement | 3.55e-04 | 11 | 76 | 2 | EFO_0005092, EFO_0006514 | |
| Disease | Metastatic melanoma | 3.71e-04 | 54 | 76 | 3 | C0278883 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 5.01e-04 | 13 | 76 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | serum gamma-glutamyl transferase measurement | 5.61e-04 | 914 | 76 | 9 | EFO_0004532 | |
| Disease | transitional cell carcinoma (is_marker_for) | 5.83e-04 | 63 | 76 | 3 | DOID:2671 (is_marker_for) | |
| Disease | whole-brain volume, Alzheimer's disease biomarker measurement | 5.84e-04 | 14 | 76 | 2 | EFO_0005089, EFO_0006514 | |
| Disease | carcinoma (implicated_via_orthology) | 6.11e-04 | 64 | 76 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Neoplasms, Experimental | 6.69e-04 | 66 | 76 | 3 | C0027659 | |
| Disease | Down syndrome (implicated_via_orthology) | 6.73e-04 | 15 | 76 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | T-Cell Lymphoma | 7.67e-04 | 16 | 76 | 2 | C0079772 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 7.67e-04 | 16 | 76 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | dysmenorrheic pain measurement | 7.67e-04 | 16 | 76 | 2 | EFO_0007889 | |
| Disease | Van Buchem disease | 8.68e-04 | 17 | 76 | 2 | C0432272 | |
| Disease | Hemangiosarcoma | 9.75e-04 | 18 | 76 | 2 | C0018923 | |
| Disease | hippocampal volume | 1.03e-03 | 297 | 76 | 5 | EFO_0005035 | |
| Disease | hair colour measurement | 1.04e-03 | 615 | 76 | 7 | EFO_0007822 | |
| Disease | Disproportionate short stature | 1.05e-03 | 77 | 76 | 3 | C0878659 | |
| Disease | Juvenile Myelomonocytic Leukemia | 1.09e-03 | 19 | 76 | 2 | C0349639 | |
| Disease | calcium measurement | 1.18e-03 | 628 | 76 | 7 | EFO_0004838 | |
| Disease | FEV/FEC ratio | 1.18e-03 | 1228 | 76 | 10 | EFO_0004713 | |
| Disease | base metabolic rate measurement | 1.21e-03 | 20 | 76 | 2 | EFO_0007777 | |
| Disease | Papillary thyroid carcinoma | 1.44e-03 | 86 | 76 | 3 | C0238463 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.46e-03 | 189 | 76 | 4 | EFO_0009932 | |
| Disease | Splenomegaly | 1.46e-03 | 22 | 76 | 2 | C0038002 | |
| Disease | triacylglycerol 58:9 measurement | 1.46e-03 | 22 | 76 | 2 | EFO_0010443 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERSKVPYIVRQCVEE | 656 | Q12979 | |
| VRKEREYVIPKRNEI | 431 | Q5RHP9 | |
| RAEEIYPIKERNNRT | 121 | P49662 | |
| DREFVFKEPQQVVRR | 51 | Q96Q83 | |
| RKINEARECYRPVAA | 3696 | Q96DT5 | |
| EKRFEIQRYLSTPER | 126 | Q3C1V8 | |
| EKRYVVQVREDVTPG | 401 | Q9HCU4 | |
| IKYRQTTQDAPEEVR | 41 | Q9P013 | |
| VAEEFYRKEKRPVTR | 1391 | Q9P1Z9 | |
| PLDETEKRCQVYQRR | 321 | Q7L7V1 | |
| PEETVSKRDYVRLVV | 151 | P36575 | |
| YREQIKRVKDSDDVP | 96 | P01112 | |
| YREQIKRVKDSEDVP | 96 | P01116 | |
| YREQIKRVKDSDDVP | 96 | P01111 | |
| TYLEEELVKARERPR | 491 | Q96DU7 | |
| TVPEEEREAKFYRVV | 211 | O94822 | |
| KFVCEYRRPVAERAQ | 746 | Q6IWH7 | |
| EYQRRQVREPSDKFV | 896 | Q86T65 | |
| KSRREPRTYTEEELN | 1811 | Q7RTP6 | |
| DDRGPVVRKQRYVFD | 211 | P43026 | |
| VRVYERKKEDQRQPS | 1241 | Q8IWI9 | |
| YRDAEIVRTRDPEKL | 71 | Q9HB07 | |
| EVLYIQRPIEEDRRK | 891 | Q9ULI0 | |
| SQDYRVVAAQRKEEP | 346 | P0C7T5 | |
| EVPYEDIRLRRQKEA | 181 | P51511 | |
| RDKPRAIVVNAERGY | 1066 | O75197 | |
| RKAAEPEVEVEVYRR | 71 | Q6ICG6 | |
| YRDSREINAVVTPER | 896 | Q5T0W9 | |
| KVERFRYSRVEDPTD | 611 | Q92824 | |
| AEPEENKRTRTAYTR | 141 | P52945 | |
| VQEPRVRAKYRGIET | 1051 | P51805 | |
| RDLEVPGYRQERVEK | 1336 | Q9HCM2 | |
| ELPVDYREAKRRVTG | 26 | A6NFU8 | |
| VRKAVPDAVESRYSR | 716 | P16284 | |
| VEERARERVPYGVSV | 256 | Q9BQ89 | |
| RERVPYGVSVVERNA | 261 | Q9BQ89 | |
| RDGVRLKVQYRPEEF | 1571 | Q8TDM6 | |
| EPRRQAVRSYNSEVK | 1386 | Q6YHK3 | |
| IYEIEDRTRVQPKFR | 341 | Q8NHM5 | |
| RQTIVPVCSYEEREK | 226 | P56159 | |
| AVFREPYTVRVEDQR | 121 | Q8TD84 | |
| TEIDQDKYAVRFIPR | 2381 | P21333 | |
| AKRRTKRDVYQEPTD | 101 | P09958 | |
| VRIRSDKDNDIPIRY | 191 | P55283 | |
| AAEELKYRRDIRPEV | 681 | Q13634 | |
| VVRIAPEERQKYEEE | 406 | Q12840 | |
| VARLTPYEVDELRRK | 141 | Q92841 | |
| SEKRYVAQVREDVRP | 546 | Q9NYQ7 | |
| RFIQARRTYTEDPKE | 1341 | Q96RY7 | |
| PRVRDDVAEYKRLNF | 256 | Q13895 | |
| YQIVVEEERPRRTKK | 621 | P28827 | |
| VRIAIKEIPERDSRY | 676 | Q6ZN16 | |
| VLREPYTVRVEDQKT | 121 | O60469 | |
| REPVSDYQVLREKAA | 166 | Q7Z7C8 | |
| IRAYRAQKERDFEDP | 81 | Q15464 | |
| RENVRKRLYPSREEF | 1431 | P21675 | |
| RYDDEVKRVVAEPVE | 211 | O75489 | |
| EKVSYRELQERCRPQ | 2061 | P58107 | |
| VDPSKIDEIRRTVYV | 56 | Q8WXA9 | |
| KNSARPRDEVQEVVY | 26 | Q12765 | |
| LRVVEEPYTVREARI | 116 | O75153 | |
| EKEVAALCRYTPRRN | 391 | P12956 | |
| TVQYKDRDGRPQVVR | 2126 | P22105 | |
| RDNYERAEKRPILSV | 101 | Q8NE00 | |
| EREAEKVRYLAERIP | 36 | P19237 | |
| VVPERDRKEVYDDVL | 381 | Q6NWY9 | |
| ETPEERQDIERYSKR | 76 | O15318 | |
| ERVREYSQKVLERQP | 91 | Q8N5M4 | |
| EQRVYRRKELEEVSP | 136 | Q15149 | |
| TQVPETREVYKSEDR | 81 | Q8N720 | |
| AVYDACRVIRERVPE | 26 | Q9Y4G6 | |
| ERSREAKRPRYDDTV | 266 | Q5VUA4 | |
| ADYQPVARAVRERVA | 501 | Q96J92 | |
| RPRIAYLSEVKEERD | 401 | P36508 | |
| PERKESSRRYEEQEL | 896 | Q5T200 | |
| VYESRRVTDPERQDL | 36 | Q9P2T0 | |
| EAREKRRSYLTPVRD | 611 | O60237 | |
| YPLVEDKEEVQRKRR | 326 | Q00653 |